IRIS BIOTECHNOLOGIES INC (IRSB) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 120 transactions totaling $101.5K, demonstrating a bullish sentiment with $22.9K in net insider flow. The most recent transaction on Dec 20, 2017 involved a transaction of 390,600 shares valued at $31.2K.
No significant insider buying has been recorded for IRSB in the recent period.
No significant insider selling has been recorded for IRSB in the recent period.
Based on recent SEC filings, insider sentiment for IRSB is bullish with an Insider Alignment Score of 61/100 and a net flow of $22.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at IRIS BIOTECHNOLOGIES INC (IRSB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading IRSB stock, having executed 120 transactions in the past 90 days. The most active insider is Simon Chin (Executive), who has made 108 transactions totaling $851.1K.
Get notified when executives and directors at IRSB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 20, 2017 | Chin Simon | Executive | Other | 390,600 | $0.08 | $31.2K | |
| Nov 17, 2017 | Chin Simon | Executive | Other | 347,222 | $0.12 | $41.7K | |
| Sep 15, 2017 | Chin Simon | Executive | Other | 312,500 | $0.10 | $31.3K | |
| Aug 9, 2017 | Chin Simon | Executive | Other | 416,670 | $0.10 | $41.7K | |
| Jun 2, 2017 | Chin Simon | Executive | Other | 198,413 | $0.21 | $41.7K | |
| Mar 9, 2017 | Chin Simon | Executive | Other | 339,674 | $0.18 | $61.1K | |
| Dec 23, 2016 | Chin Simon | Executive | Other | 320,500 | $0.13 | $41.7K | |
| Dec 2, 2016 | Chin Simon | Executive | Sale | 20,000 | $0.08 | $1.6K | |
| Dec 2, 2016 | Chin Simon | Executive | Sale | 1,250 | $0.10 | $125 | |
| Dec 1, 2016 | Chin Simon | Executive | Sale | 10,000 | $0.11 | $1.1K | |
| Dec 1, 2016 | Chin Simon | Executive | Sale | 10,000 | $0.09 | $900 | |
| Nov 30, 2016 | Chin Simon | Executive | Sale | 2,500 | $0.11 | $275 | |
| Nov 30, 2016 | Chin Simon | Executive | Sale | 10,000 | $0.09 | $900 | |
| Nov 29, 2016 | Chin Simon | Executive | Sale | 10,000 | $0.09 | $900 | |
| Nov 28, 2016 | Chin Simon | Executive | Sale | 2,500 | $0.12 | $300 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 11 | $715.0K | 71.1% |
Exercise(M) | 2 | $120.0K | 11.9% |
Discretionary(I) | 4 | $68.8K | 6.8% |
Purchase(P) | 70 | $62.2K | 6.2% |
Sale(S) | 26 | $39.3K | 3.9% |
Conversion(C) | 1 | $3 | 0.0% |
Gift(G) | 6 | $0 | 0.0% |
Insiders at IRIS BIOTECHNOLOGIES INC are accumulating shares at an accelerated pace. With 5 insiders making 120 transactions totaling $62.2K in purchases versus $39.3K in sales, the net buying activity of $22.9K signals strong executive confidence. Simon Chin (Executive) leads the buying activity with $851.1K in transactions across all time.